Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Laboratory Corporation of America (LH) PT Raised to $260 at BofA Securities
August 5, 2024 5:41 AM EDTBofA Securities analyst Derik de Bruin raised the price target on Laboratory Corporation of America (NYSE: LH) to $260.00 (from $240.00) while maintaining a Buy rating.
The analyst comments "Much of the call focused on LCD margin dynamics, including Invitae contribution. Core LCD is executing... More
